McVicar William K.'s Form 4 filing
Decoy Therapeutics Inc. (DCOY) · filed Jun 7, 2022
- Accession no.
- 0001615219-22-000097
- Filed
- Jun 7, 2022, 4:33 PM ET
- Trade date
- Jun 6, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $5.00K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McVicar William K.CIK 0001634368 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Common Stock | PPurchaseAcquired | +26,553 | $0.1883 | +$4,999.93 | 26,553 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.